Richard Sassun, Francesco Brucchi, Annaclara Sileo, Barbara Vignati, Jacopo Crippa, Pietro Achilli, Dario Maggioni, Antonino Spinelli, Isacco Montroni, Alexander T. Hawkins, Giulio Mari
Introduction
Recurrent diverticulitis after resection remains a key concern despite advances in minimally invasive surgery. These recurrences may result from incomplete resection of the diseased segment, unrecognized synchronous diverticulosis or ongoing alterations in colonic motility and microbiome composition. This systematic review and single-arm meta-analysis aimed to estimate long-term recurrence and stoma rates following elective surgery for left-sided diverticulitis.
Methods
Following PRISMA guidelines and PROSPERO registration, PubMed, Cochrane and Scopus databases were searched (2000–2025) for studies reporting recurrence after elective resection. Single-arm meta-analysis of proportions was performed using random-effects models. Quality was assessed using the JBI Checklist, while subgroup and sensitivity analyses explored heterogeneity. A comparative meta-analysis with medical treatment was not performed due to selection bias, crossover and lack of standardized non-operative protocols.
Results
Twenty-four studies (7,525 patients; mean follow-up 53 months) were included. Pooled recurrence rate was 6.2% (95% CI: 4.8–8.0%; I2 = 80.6%), with no difference between RCTs (6.3%) and observational studies (6.1%) or complicated vs. uncomplicated disease. Stoma rate (16 studies, 6,400 patients) was 17.1% (95% CI: 8.4–31.9%; I2 = 99.3%), significantly higher in complicated (31.0%) than uncomplicated (5.5%) cases (p = 0.009) and significantly lower post-2020 (8.0% vs. 31.2%; p = 0.003). Quality was high in 92% of studies, while sensitivity analyses confirmed robustness.
Conclusions
Surgical resection achieves durable control with low recurrence and stoma rates. Research priorities include standardized definitions of recurrence, assessing long-term QOL and exploring microbiome influences to refine patient selection and minimize residual risk.
导论：尽管微创手术取得了进展，但憩室炎切除术后复发仍然是一个关键问题。这些复发可能是由于病变部分切除不完全，未被识别的同步憩室病或结肠运动和微生物组成的持续改变。本系统综述和单臂荟萃分析旨在评估左侧憩室炎择期手术后的长期复发和造口率。方法：按照PRISMA指南和PROSPERO注册，检索PubMed、Cochrane和Scopus数据库（2000-2025），查找报告择期切除后复发的研究。采用随机效应模型对比例进行单臂meta分析。使用JBI检查表评估质量，亚组分析和敏感性分析探讨异质性。由于选择偏倚、交叉和缺乏标准化的非手术方案，没有进行与药物治疗的比较荟萃分析。结果：纳入24项研究（7525例患者，平均随访53个月）。合并复发率为6.2% (95% CI: 4.8-8.0%; I2 = 80.6%)，随机对照试验（6.3%）与观察性研究（6.1%）、并发症与非并发症之间无差异。造口率（16项研究，6400例患者）为17.1% (95% CI: 8.4 ~ 31.9%, I2 = 99.3%)，并发症组（31.0%）显著高于无并发症组（5.5%）（p = 0.009）， 2020年后组（8.0% vs. 31.2%, p = 0.003）显著低于并发症组（8.0% vs. 31.2%）。92%的研究质量高，敏感性分析证实了稳健性。结论：手术切除获得持久的控制，复发率和造口率低。研究重点包括标准化复发定义，评估长期生活质量和探索微生物组的影响，以优化患者选择和最小化剩余风险。
{"title":"Recurrent left-sided diverticulitis after surgery: A systematic review and single arm meta-analysis","authors":"Richard Sassun, Francesco Brucchi, Annaclara Sileo, Barbara Vignati, Jacopo Crippa, Pietro Achilli, Dario Maggioni, Antonino Spinelli, Isacco Montroni, Alexander T. Hawkins, Giulio Mari","doi":"10.1111/codi.70368","DOIUrl":"10.1111/codi.70368","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Recurrent diverticulitis after resection remains a key concern despite advances in minimally invasive surgery. These recurrences may result from incomplete resection of the diseased segment, unrecognized synchronous diverticulosis or ongoing alterations in colonic motility and microbiome composition. This systematic review and single-arm meta-analysis aimed to estimate long-term recurrence and stoma rates following elective surgery for left-sided diverticulitis.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Following PRISMA guidelines and PROSPERO registration, PubMed, Cochrane and Scopus databases were searched (2000–2025) for studies reporting recurrence after elective resection. Single-arm meta-analysis of proportions was performed using random-effects models. Quality was assessed using the JBI Checklist, while subgroup and sensitivity analyses explored heterogeneity. A comparative meta-analysis with medical treatment was not performed due to selection bias, crossover and lack of standardized non-operative protocols.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Twenty-four studies (7,525 patients; mean follow-up 53 months) were included. Pooled recurrence rate was 6.2% (95% CI: 4.8–8.0%; <i>I</i><sup>2</sup> = 80.6%), with no difference between RCTs (6.3%) and observational studies (6.1%) or complicated vs. uncomplicated disease. Stoma rate (16 studies, 6,400 patients) was 17.1% (95% CI: 8.4–31.9%; <i>I</i><sup>2</sup> = 99.3%), significantly higher in complicated (31.0%) than uncomplicated (5.5%) cases (<i>p</i> = 0.009) and significantly lower post-2020 (8.0% vs. 31.2%; <i>p</i> = 0.003). Quality was high in 92% of studies, while sensitivity analyses confirmed robustness.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Surgical resection achieves durable control with low recurrence and stoma rates. Research priorities include standardized definitions of recurrence, assessing long-term QOL and exploring microbiome influences to refine patient selection and minimize residual risk.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 1","pages":""},"PeriodicalIF":2.7,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145951479","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"In my hands, in my theatre, in spite of evidence—The implementation gap in surgery","authors":"Arabella Scantlebury, Amy Grove","doi":"10.1111/codi.70372","DOIUrl":"10.1111/codi.70372","url":null,"abstract":"","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 1","pages":""},"PeriodicalIF":2.7,"publicationDate":"2026-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145951508","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Antoine Cazelles, Quentin Denost, Benjamin Fernandez, Michel Rivoire, Hélène Meillat, Philippe Rouanet, Mehdi Karoui, Adeline Germain, Leon Maggiori, Alain Valverde, Nicolas Peru, Eddy Cotte, Etienne Buscail, Jeremie H. Lefevre, Bertrand Trilling, Jean Luc Faucheron, Pierre Yves Sage, Laura Beyer-Berjot, Stephane Benoist, Arnaud Alves, Charles Sabbagh, Jean-Jacques Tuech, Julien Coget, Frédéric Marchal, Guillaume Meurette, Diane Mège, Dahbia Djelil, Simone Manfredelli, Aurélien Venara, Mehdi Ouaissi, Gilles Manceau, French Research Group of Rectal Cancer Surgery (GRECCAR)
Aim
Neoadjuvant treatment for rectal cancer has evolved markedly with the growing adoption of total neoadjuvant therapy (TNT), organ-preservation strategies and selective omission of radiotherapy. Recent trials support risk-based personalization, but its application in real-world settings remains poorly documented. The aim was to describe current neoadjuvant treatment practices for mid-low rectal cancer in French expert centres and identify tumour- and patient-related factors influencing decisions.
Method
This observational study included patients with non-metastatic rectal adenocarcinoma ≤10 cm from the anal verge, discussed in tumour boards (October 2022 to March 2023) across GRECCAR centres. Tumours were classified as early, intermediate-risk or locally advanced rectal cancer (LARC). Neoadjuvant treatments were analysed according to tumour extension, location and age.
Results
Among 463 patients from 27 centres, the most frequent regimen was induction chemotherapy, mainly FOLFIRINOX, followed by long-course chemoradiotherapy (CRT) (65%). This approach was used in 51%, 66% and 71% of patients in the early, intermediate-risk and LARC groups, respectively (p = 0.0060). TNT was more frequently administered for low- than mid-rectal cancers, especially in LARC (86% vs. 71%, p = 0.016). In patients >75 years, CRT + consolidation chemotherapy and radiotherapy alone were proportionally more frequent. Among the early rectal cancers, those treated with induction chemotherapy + CRT had more advanced features than those treated with CRT alone (cT3: 80% vs. 43%, cN+: 62% vs. 10%, tumour size: 3.4 vs. 2.3 cm; all p < 0.001).
Conclusion
TNT with induction chemotherapy is the predominant neoadjuvant approach in French expert centres. Tumour classification, location and patient age significantly influence treatment choices, reflecting a shift towards personalized context-specific care.
目的：随着全新辅助治疗（TNT）、器官保存策略和选择性省略放疗的日益普及，直肠癌的新辅助治疗有了显著的发展。最近的试验支持基于风险的个性化，但其在现实环境中的应用仍然缺乏记录。目的是描述目前法国专家中心中低位直肠癌的新辅助治疗实践，并确定影响决策的肿瘤和患者相关因素。方法：这项观察性研究纳入了距肛门边缘≤10厘米的非转移性直肠腺癌患者，在grecar中心的肿瘤委员会（2022年10月至2023年3月）进行了讨论。肿瘤分为早期、中危或局部晚期直肠癌（LARC）。根据肿瘤范围、部位和年龄分析新辅助治疗方法。结果：在27个中心的463例患者中，最常见的方案是诱导化疗，主要是FOLFIRINOX，其次是长疗程放化疗（CRT）（65%）。早期、中危和LARC组分别有51%、66%和71%的患者采用该方法（p = 0.0060）。TNT更常用于低位直肠癌而非中位直肠癌，尤其是LARC（86%对71%，p = 0.016）。在年龄0 ~ 75岁的患者中，单纯CRT +巩固化疗和放疗的比例更高。在早期直肠癌中，诱导化疗+ CRT治疗的患者比单独CRT治疗的患者具有更多的晚期特征（cT3: 80% vs. 43%, cN+: 62% vs. 10%，肿瘤大小：3.4 vs. 2.3 cm）。结论：TNT联合诱导化疗是法国专家中心主要的新辅助方法。肿瘤分类、位置和患者年龄显著影响治疗选择，反映了向个性化具体情况护理的转变。
{"title":"Contemporary neoadjuvant strategies for rectal cancer: The GRECCAR snapshot study","authors":"Antoine Cazelles, Quentin Denost, Benjamin Fernandez, Michel Rivoire, Hélène Meillat, Philippe Rouanet, Mehdi Karoui, Adeline Germain, Leon Maggiori, Alain Valverde, Nicolas Peru, Eddy Cotte, Etienne Buscail, Jeremie H. Lefevre, Bertrand Trilling, Jean Luc Faucheron, Pierre Yves Sage, Laura Beyer-Berjot, Stephane Benoist, Arnaud Alves, Charles Sabbagh, Jean-Jacques Tuech, Julien Coget, Frédéric Marchal, Guillaume Meurette, Diane Mège, Dahbia Djelil, Simone Manfredelli, Aurélien Venara, Mehdi Ouaissi, Gilles Manceau, French Research Group of Rectal Cancer Surgery (GRECCAR)","doi":"10.1111/codi.70358","DOIUrl":"10.1111/codi.70358","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>Neoadjuvant treatment for rectal cancer has evolved markedly with the growing adoption of total neoadjuvant therapy (TNT), organ-preservation strategies and selective omission of radiotherapy. Recent trials support risk-based personalization, but its application in real-world settings remains poorly documented. The aim was to describe current neoadjuvant treatment practices for mid-low rectal cancer in French expert centres and identify tumour- and patient-related factors influencing decisions.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Method</h3>\u0000 \u0000 <p>This observational study included patients with non-metastatic rectal adenocarcinoma ≤10 cm from the anal verge, discussed in tumour boards (October 2022 to March 2023) across GRECCAR centres. Tumours were classified as early, intermediate-risk or locally advanced rectal cancer (LARC). Neoadjuvant treatments were analysed according to tumour extension, location and age.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Among 463 patients from 27 centres, the most frequent regimen was induction chemotherapy, mainly FOLFIRINOX, followed by long-course chemoradiotherapy (CRT) (65%). This approach was used in 51%, 66% and 71% of patients in the early, intermediate-risk and LARC groups, respectively (<i>p</i> = 0.0060). TNT was more frequently administered for low- than mid-rectal cancers, especially in LARC (86% vs. 71%, <i>p</i> = 0.016). In patients >75 years, CRT + consolidation chemotherapy and radiotherapy alone were proportionally more frequent. Among the early rectal cancers, those treated with induction chemotherapy + CRT had more advanced features than those treated with CRT alone (cT3: 80% vs. 43%, cN+: 62% vs. 10%, tumour size: 3.4 vs. 2.3 cm; all <i>p</i> < 0.001).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>TNT with induction chemotherapy is the predominant neoadjuvant approach in French expert centres. Tumour classification, location and patient age significantly influence treatment choices, reflecting a shift towards personalized context-specific care.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 1","pages":""},"PeriodicalIF":2.7,"publicationDate":"2026-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145942809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Carlo Alberto Manzo, Giulia De Carlo, Leonardo Lorusso, Caterina Baldi, Gianluca Matteo Sampietro
Background
Surgical management of Crohn‘s disease remains challenging because of disease complexity and substantial variability in operative techniques across centres. Despite the widespread adoption of minimally invasive surgery, laparoscopic ileocolic resection is still characterized by limited technical standardization and heterogeneous perioperative outcomes. Unlike oncological colorectal surgery, inflammatory bowel disease surgery lacks widely accepted, reproducible technical frameworks.
Objective
To describe a standardized five-step, three-trocar laparoscopic ileocolic resection for Crohn‘s disease, aimed at improving reproducibility, safety, and operative efficiency in both elective and emergency settings.
Methods
This technical note details a structured laparoscopic approach based on: (1) systematic intraoperative bowel assessment, (2) a bottom-up medial-to-lateral dissection, (3) mandatory identification of retroperitoneal structures, (4) selective mesenteric division using a ‘clip-and-go’ technique with preservation of the main ileocolic vessels and (5) a standardized intracorporeal isoperistaltic side-to-side anastomosis. The technique is illustrated by a dedicated surgical video, including complex inflammatory scenarios such as thickened mesentery and abscess formation. A consecutive cohort of patients undergoing laparoscopic ileocolic resection for Crohn‘s disease between 2020 and 2025 at a tertiary IBD referral centre was retrospectively analysed.
Results
A total of 110 patients were included. No conversions to open surgery occurred. The mean operative time for isolated ileocolic resection was 116 minutes. The anastomotic dehiscence rate was 2.7%, supporting the feasibility and safety of the standardized laparoscopic workflow in real-life Crohn‘s disease surgery.
Conclusions
The proposed five-step, three-trocar laparoscopic ileocolic resection represents a reproducible and safe technical framework for Crohn‘s disease surgery. This standardized approach may reduce intraoperative variability, facilitate surgical training, and contribute to more consistent perioperative outcomes in inflammatory bowel disease.
{"title":"A standardized five-step three-trocar laparoscopic ileocolic resection for Crohn's disease: A 5-year real-life experience from a tertiary IBD centre","authors":"Carlo Alberto Manzo, Giulia De Carlo, Leonardo Lorusso, Caterina Baldi, Gianluca Matteo Sampietro","doi":"10.1111/codi.70360","DOIUrl":"10.1111/codi.70360","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Surgical management of Crohn‘s disease remains challenging because of disease complexity and substantial variability in operative techniques across centres. Despite the widespread adoption of minimally invasive surgery, laparoscopic ileocolic resection is still characterized by limited technical standardization and heterogeneous perioperative outcomes. Unlike oncological colorectal surgery, inflammatory bowel disease surgery lacks widely accepted, reproducible technical frameworks.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To describe a standardized five-step, three-trocar laparoscopic ileocolic resection for Crohn‘s disease, aimed at improving reproducibility, safety, and operative efficiency in both elective and emergency settings.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This technical note details a structured laparoscopic approach based on: (1) systematic intraoperative bowel assessment, (2) a bottom-up medial-to-lateral dissection, (3) mandatory identification of retroperitoneal structures, (4) selective mesenteric division using a ‘clip-and-go’ technique with preservation of the main ileocolic vessels and (5) a standardized intracorporeal isoperistaltic side-to-side anastomosis. The technique is illustrated by a dedicated surgical video, including complex inflammatory scenarios such as thickened mesentery and abscess formation. A consecutive cohort of patients undergoing laparoscopic ileocolic resection for Crohn‘s disease between 2020 and 2025 at a tertiary IBD referral centre was retrospectively analysed.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>A total of 110 patients were included. No conversions to open surgery occurred. The mean operative time for isolated ileocolic resection was 116 minutes. The anastomotic dehiscence rate was 2.7%, supporting the feasibility and safety of the standardized laparoscopic workflow in real-life Crohn‘s disease surgery.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>The proposed five-step, three-trocar laparoscopic ileocolic resection represents a reproducible and safe technical framework for Crohn‘s disease surgery. This standardized approach may reduce intraoperative variability, facilitate surgical training, and contribute to more consistent perioperative outcomes in inflammatory bowel disease.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 1","pages":""},"PeriodicalIF":2.7,"publicationDate":"2026-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145932426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Robotic-assisted excision of a mesorectal sclerosing epithelioid fibrosarcoma in an obese patient: A video vignette","authors":"Arcangelo Picciariello, Agnese Dezi, Leonardo Vincenti","doi":"10.1111/codi.70359","DOIUrl":"10.1111/codi.70359","url":null,"abstract":"","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 1","pages":""},"PeriodicalIF":2.7,"publicationDate":"2026-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145932553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Siu, A.H., Gibson, D.P., Chiu, C., Kwok, A., Irwin, M., Christie, A., Koh, C.E., Keshava, A., Reece, M., Suen, M. and Rickard, M.J., 2025. ChatGPT as a patient education tool in colorectal cancer—An in-depth assessment of efficacy, quality and readability. Colorectal Disease, 27(1), p. e17267.
In the published article, the authorship contribution was incorrectly stated.
Correct Information: Adrian Siu and Damien Gibson contributed equally and should be recognized as joint first authors.
We apologize for this error.
Siu, a.h., Gibson, d.p., Chiu， C, Kwok， A., Irwin， M., Christie， A., Koh, c.e., Keshava， A., Reece， M., Suen， M.和Rickard， m.j., 2025。ChatGPT作为结直肠癌患者教育工具的疗效、质量和可读性的深入评估结直肠疾病杂志，27(1),p. 1767。在这篇发表的文章中，作者的贡献被错误地写了出来。正确信息：Adrian Siu和Damien Gibson贡献相同，应被视为共同第一作者。我们为这个错误道歉。
{"title":"Correction to ‘ChatGPT as a patient education tool in colorectal cancer—An in-depth assessment of efficacy, quality and readability’","authors":"","doi":"10.1111/codi.70367","DOIUrl":"10.1111/codi.70367","url":null,"abstract":"<p>Siu, A.H., Gibson, D.P., Chiu, C., Kwok, A., Irwin, M., Christie, A., Koh, C.E., Keshava, A., Reece, M., Suen, M. and Rickard, M.J., 2025. ChatGPT as a patient education tool in colorectal cancer—An in-depth assessment of efficacy, quality and readability. <i>Colorectal Disease</i>, <i>27</i>(1), p. e17267.</p><p>In the published article, the authorship contribution was incorrectly stated.</p><p><b>Correct Information:</b> Adrian Siu and Damien Gibson contributed equally and should be recognized as joint first authors.</p><p>We apologize for this error.</p>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 1","pages":""},"PeriodicalIF":2.7,"publicationDate":"2026-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/codi.70367","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145917299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sthela M. Murad-Regadas, Jose Jader Araujo de Mendonça Filho, F Sergio P. Regadas Filho, Carlos Magno Queiroz da Cunha, Matheus E. de Brito Castelo Branco, Marina Murad Regadas
{"title":"Perineal rupture: Overlapping or end-to-end sphincteroplasty? A video vignette","authors":"Sthela M. Murad-Regadas, Jose Jader Araujo de Mendonça Filho, F Sergio P. Regadas Filho, Carlos Magno Queiroz da Cunha, Matheus E. de Brito Castelo Branco, Marina Murad Regadas","doi":"10.1111/codi.70357","DOIUrl":"10.1111/codi.70357","url":null,"abstract":"","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 1","pages":""},"PeriodicalIF":2.7,"publicationDate":"2026-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145910684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Reassessing drainage strategies for anastomotic leak after elective anterior resection: Insights from a systematic review and pooled analysis","authors":"Sithdharthan Ravikumar, Aravindan Narayanan","doi":"10.1111/codi.70361","DOIUrl":"10.1111/codi.70361","url":null,"abstract":"","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 1","pages":""},"PeriodicalIF":2.7,"publicationDate":"2026-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145910750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Eleftherios Gialamas, Isabelle Uhe, Pierre-Alain Tokoto, Emilie Liot, Frédéric Ris, Steven D. Wexner, Jeremy Meyer, Guillaume Meurette, the International Rectopexy Collaborative Group
Aim
Rectopexy is the preferred abdominal intervention for rectal prolapse. Despite similar procedural steps – rectal mobilisation, prolapse reduction, and fixation – techniques vary widely, and onsensus on the optimal approach is lacking. This study aimed to assess global surgeon preferences and practices in rectopexy.
Methods
An international 28-item online survey was distributed between November 2023 and March 2024 through professional networks and social media. Questions addressed surgeon demographics, perioperative strategies, and technical approaches to rectopexy. Responses were analysed descriptively and stratified by region and specialty.
Results
A total of 226 surgeons from 36 countries across four continents completed the survey. Most respondents (79.6%) administered preoperative intravenous antibiotics, and 80.5% used some form of mechanical bowel preparation. Minimally invasive approaches predominated (81%), with laparoscopy being most common. Posterior dissection was preferred by 61.5%, while 38.5% favoured ventral (anterior) dissection. Two-thirds (68.1%) routinely used mesh, predominantly synthetic. Only 15% performed rectopexy as a day-case procedure. Regional and specialty-related variations were evident in approach, mesh type, and perioperative protocols.
Conclusion
This international survey reveals marked variability in rectopexy practice worldwide. Despite common principles, surgeon preference and regional factors strongly influence decision-making. The findings emphasise the need for updated international guidelines to harmonise technique selection and perioperative management in rectal prolapse surgery.
{"title":"Surgeon preferences and practice patterns in rectopexy: Results of an international survey","authors":"Eleftherios Gialamas, Isabelle Uhe, Pierre-Alain Tokoto, Emilie Liot, Frédéric Ris, Steven D. Wexner, Jeremy Meyer, Guillaume Meurette, the International Rectopexy Collaborative Group","doi":"10.1111/codi.70355","DOIUrl":"10.1111/codi.70355","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>Rectopexy is the preferred abdominal intervention for rectal prolapse. Despite similar procedural steps – rectal mobilisation, prolapse reduction, and fixation – techniques vary widely, and onsensus on the optimal approach is lacking. This study aimed to assess global surgeon preferences and practices in rectopexy.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>An international 28-item online survey was distributed between November 2023 and March 2024 through professional networks and social media. Questions addressed surgeon demographics, perioperative strategies, and technical approaches to rectopexy. Responses were analysed descriptively and stratified by region and specialty.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>A total of 226 surgeons from 36 countries across four continents completed the survey. Most respondents (79.6%) administered preoperative intravenous antibiotics, and 80.5% used some form of mechanical bowel preparation. Minimally invasive approaches predominated (81%), with laparoscopy being most common. Posterior dissection was preferred by 61.5%, while 38.5% favoured ventral (anterior) dissection. Two-thirds (68.1%) routinely used mesh, predominantly synthetic. Only 15% performed rectopexy as a day-case procedure. Regional and specialty-related variations were evident in approach, mesh type, and perioperative protocols.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>This international survey reveals marked variability in rectopexy practice worldwide. Despite common principles, surgeon preference and regional factors strongly influence decision-making. The findings emphasise the need for updated international guidelines to harmonise technique selection and perioperative management in rectal prolapse surgery.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 1","pages":""},"PeriodicalIF":2.7,"publicationDate":"2026-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12765771/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145899227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号